Brit Mollenhauer - Concepedia

Author

Brit Mollenhauer

Also Known As

Aarsland, Dag, Anastasia Illarionova, Arthur Toga, B Mollenhauer, B. Mollenhauer, B.R.I.T. Mollenhauer, Brit Mollenhauer, Claudia Trenkwalder, Douglas Galasko, Jaco Knol

473

Publications

38.9K

Citations

H-Index

179

Concepts

All Affiliations

Paracelsus Elena Klinik Kassel University of Göttingen Universitätsmedizin Göttingen German Center for Neurodegenerative Diseases Philipps University of Marburg

About

Brit Mollenhauer is an author at Paracelsus Elena Klinik Kassel specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	70	8.5K
2	Engineering	5	5	162
3	Health Sciences	4	4	1.3K
4	Public Health	4	4	229
5	Natural Sciences	2	2	87

Brit Mollenhauer

214

Publications

24K

Citations

H-Index

Page 1

	Year	Citations
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria Günter U. Höglinger, Gesine Respondek, María Stamelou, Movement Disorders	2017	2.2K
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study Ronald B. Postuma, Álex Iranzo, Birgit Högl, Brain Sleep DisordersDementia Underwent SleepIdiopathic RemGeriatric NeurologySleep Medicine	2019	1K
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease Alexander Zimprich, Anna Benet‐Pagès, Walter Struhal, The American Journal of Human Genetics Late-onset Parkinson DiseaseRetromer ComplexNeurodegenerative DiseasesGenetic DisorderGenetics	2011	876
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI Irene Litvan, Dag Aarsland, Charles H. Adler, Movement Disorders	2011	789
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Annals of Clinical and Translational Neurology	2018	633
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study Brit Mollenhauer, Joseph J. Locascio, Walter Schulz‐Schaeffer, The Lancet Neurology Neurodegenerative DiseasesCerebrospinal FluidParkinson DiseaseNeurochemical BiomarkersCohort Study	2011	624
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, The Lancet Neurology Neurodegenerative DiseasesDisease ProgressionParkinson DiseaseNeurologyMedicine	2023	618
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder Anna Heintz‐Buschart, Urvashi Pandey, Tamara Wicke, Movement Disorders	2017	554
A Practical Guide to Immunoassay Method Validation Ulf Andréasson, Armand Perret‐Liaudet, Linda Josephine Christine van Waalwijk van Doorn, Frontiers in Neurology Biochemical MarkersImmunologyDiagnosisNeurochemical BiomarkersBiomarker (Medicine)	2015	520
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid Mohammad Shahnawaz, Takahiko Tokuda, Masaaki Waragai, JAMA Neurology	2016	488

Page 1